BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7191515)

  • 1. Ultrastructural localization of acetylcholine receptor at the motor endplate: myasthenia gravis and other neuromuscular diseases.
    Tsujihata M; Hazama R; Ishii N; Ide Y; Takamori M
    Neurology; 1980 Nov; 30(11):1203-11. PubMed ID: 7191515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model.
    Engel AG; Lindstrom JM; Lambert EH; Lennon VA
    Neurology; 1977 Apr; 27(4):307-15. PubMed ID: 557772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limb muscle endplates in ocular myasthenia gravis: quantitative ultrastructural study.
    Tsujihata M; Hazama R; Ishii N; Ide Y; Mori M; Takamori M
    Neurology; 1979 May; 29(5):654-61. PubMed ID: 571563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in related neuromuscular diseases (author's transl)].
    Tsujihata M; Hazama R; Ishii N; Ide Y; Takamori M
    Rinsho Shinkeigaku; 1979 Nov; 19(11):751-9. PubMed ID: 535300
    [No Abstract]   [Full Text] [Related]  

  • 5. The motor end-plate fine structure and ultrastructural localization of acetylcholine receptors in amyotrophic lateral sclerosis.
    Tsujihata M; Hazama R; Yoshimura T; Satoh A; Mori M; Nagataki S
    Muscle Nerve; 1984; 7(3):243-9. PubMed ID: 6708970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunopathological basis of acetylcholine receptor deficiency in myasthenia gravis.
    Engel AG
    Prog Brain Res; 1979; 49():423-34. PubMed ID: 515440
    [No Abstract]   [Full Text] [Related]  

  • 7. The acetylcholine receptor in normal and pathologic states. Immunoperoxidase visualization of alpha-bungarotoxin binding at a light and electron-microscopic level.
    Bender AN; Ringel SP; Engel WK
    Neurology; 1976 May; 26(5):477-83. PubMed ID: 177905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to motor endplates demonstrated with the immunofluorescence technique.
    Sondag-Tschroots IR; Schulz-Raateland RC; van Walbeek HK; Feltkamp TE
    Clin Exp Immunol; 1979 Aug; 37(2):323-7. PubMed ID: 387311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study.
    Engel AG; Tsujihata M; Lindstrom JM; Lennon VA
    Ann N Y Acad Sci; 1976; 274():60-79. PubMed ID: 1066997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic difference of acetylcholine receptor between single and multiple form endplates of human extraocular muscle.
    Oda K; Shibasaki H
    Brain Res; 1988 May; 449(1-2):337-40. PubMed ID: 2456129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The motor end-plate in ocular and generalized myasthenia gravis: a quantitative ultrastructural study (author's transl)].
    Tsujihata M; Hazama R; Takamori M; Shibuya N; Mori K
    Rinsho Shinkeigaku; 1978 Mar; 18(3):149-56. PubMed ID: 668254
    [No Abstract]   [Full Text] [Related]  

  • 13. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro.
    Burges J; Wray DW; Pizzighella S; Hall Z; Vincent A
    Muscle Nerve; 1990 May; 13(5):407-13. PubMed ID: 2345558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases.
    Vincent A; Cull-Candy SG; Newsom-Davis J; Trautmann A; Molenaar PC; Polak RL
    Muscle Nerve; 1981; 4(4):306-18. PubMed ID: 7254233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunopathology of acquired myasthenia gravis.
    Engel AG; Sahashi K; Fumagalli G
    Ann N Y Acad Sci; 1981; 377():158-74. PubMed ID: 6951470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ultrastructural study on the muscle end-plates in a case of myasthenia gravis].
    Tu LH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Oct; 20(5):273-5. PubMed ID: 3450483
    [No Abstract]   [Full Text] [Related]  

  • 17. Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptor.
    Engel AG; Sakakibara H; Sahashi K; Lindstrom JM; Lambert EH; Lennon VA
    Neurology; 1979 Feb; 29(2):179-88. PubMed ID: 571062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An electrophysiological and morphological study of the neuromuscular junction in patients with myasthenia gravis.
    Albuquerque EX; Rash JE; Mayer RF; Satterfield JR
    Exp Neurol; 1976 Jun; 51(3):536-63. PubMed ID: 179836
    [No Abstract]   [Full Text] [Related]  

  • 19. End-plate acetylcholinesterase deficiency associated with small nerve terminals and reduced acetylcholine release. A new syndrome.
    Engel AG; Lambert EH; Gomez MR
    Int J Neurol; 1980; 14(1):73-86. PubMed ID: 6293992
    [No Abstract]   [Full Text] [Related]  

  • 20. [Histochemical findings of and fine structural changes in motor endplates in diseases with neuromuscular transmission abnormalities].
    Yoshimura T; Motomura M; Tsujihata M
    Brain Nerve; 2011 Jul; 63(7):719-27. PubMed ID: 21747142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.